Functional Variant in the α2B Adrenoceptor Gene, a Positional Candidate on Chromosome 2, Associates with Hypertension

Hypertension

Volumn 43, Issue 3, 2004, Pages 592-597

  Von Wowern, Fredrik ^a,b   Bengtsson, Kristina ^a   Lindblad, Ulf ^a   Råstam, Lennart ^a   Melander, Olle ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Malmö University Hospital   (Sweden)

Author keywords

Adrenergic; Genetics; Hypertension; Receptors

Indexed keywords

GLUTAMIC ACID;

ADULT; ALPHA2BETA ADRENOCEPTOR GENE; ARTICLE; CHROMOSOME 2; CONTROLLED STUDY; DELETION MUTANT; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOME; GENOME WIDE SCAN; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PHENOTYPE; PLEIOTROPY; POPULATION GENETICS; PRIORITY JOURNAL; SCANDINAVIA; SWEDEN;

AGED; BLOOD PRESSURE; CHROMOSOMES, HUMAN, PAIR 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, ALPHA-2; SEQUENCE DELETION;

EID: 1442288386     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000116224.51189.80     Document Type: Article

References (26)

1. Hunt S, Williams R, Barlow G. A comparison of positive family history definitions for defining risk of future disease. J Chronic Dis. 1986;39:809-821.
2. von Wowern F, Bengtsson K, Lindgren CM, Orho-Melander M, Fyhrquist F, Lindblad U, Råstam L, Forsblom C, Kanninen T, Almgren P, Burri P, Katzman P, Groop L, Hulthén UL, Melander O. A genome wide scan for early onset primary hypertension in Scandinavians. Hum Mol Genet. 2003;12:2077-2081.
3. Kristjansson K, Manolescu A, Kristinsson A, Hardarson T, Knudsen H, Ingason S, Thorleifsson G, Frigge ML, Kong A, Gulcher JR, Stefansson K. Linkage of essential hypertension to chromosome 18q. Hypertension. 2002;39:1044-1049.
4. Atwood LD, Samollow PB, Hixson JE, Stern MP, MacCluer JW. Genome-wide linkage analysis of blood pressure in Mexican Americans. Genet Epidemiol. 2001;20:373-382.
5. Rice T, Rankinen T, Province MA, Chagnon YC, Perusse L, Borecki IB, Bouchard C, Rao DC. Genome-wide linkage analysis of systolic and diastolic blood pressure: the Quebec Family Study. Circulation. 2000;102:1956-1963.
6. Cooper RS, Luke A, Zhu X, Kan D, Adeyemo A, Rorimi C, Bouzekri N, Ward R. Genome scan among Nigerians linking blood pressure to chromosomes 2, 3, and 19. Hypertension. 2002;40:629-633.
7. 2-adrenergic receptors in hypertension and heart failure: experimental and clinical studies. J Hypertens. 2001;19:2115-2124.
8. 2B-adrenergic receptor and lack of linkage with essential hypertension. Am J Hypertens. 1999;12:853-857.
9. 2B-adrenergic receptor that is associated with reduced basal metabolic rate in obese subjects. J Clin Endocrinol Metab. 1999;84:2429-2433.
10. 2B adrenergic receptors in polarized MDCKII cells requires the third intracellular loop but not G protein coupling. Mol Pharmacol. 2000;57:44-52.
11. 2B-adrenergic receptor decreases G protein-coupled receptor kinase-mediated phosphorylation and desensitization. J Biol Chem. 2001;276:4917-4922.
12. 2B-adrenergic receptor gene is associated with flow-mediated dilatation of the brachial artery. Clin Sci. 2002;103:517-524.
13. 2B-, β1- and β2-adrenoreceptors on haemodynamic responses to adrenaline. Clin Sci. 2003;104:509-520.
14. Bengtsson K, Orho-Melander M, Lindblad U, Melander O, Bøg-Hansen E, Ranstam J, Råstam L, Groop L. Polymorphism in the angiotensin converting enzyme but not in the angiotensinogen gene is associated with hypertension and type 2 diabetes: the Skaraborg Hypertension and Diabetes Project. J Hypertens. 1999;17:1569-1575.
15. Chobanian A, Bakris G, Black H, Cushman W, Green L, Izzo JJ, Jones D, Materson B, Oparil S, Wright JJ, Roccella E and the National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
16. National Board of Health and Welfare, Drug Information Committee. Treatment of mild hypertension. Vol. 1. Stockholm; 1987.
17. WHO Study Group. Diabetes Mellitus. Geneva; 1985.
18. Mogensen C, Viberti G, Peheim E, Kutter D, Hasslacher C, Hofmann W, Renner R, Bojestig M, Paulsen P, Scott G, Thoma J, Kuefer J, Nilsson B, Gambke B, Mueller P, Steinbiss J, Willamowski K. Multicenter evaluation of the Micral-Test II test strip, an immunologic rapid test for the detection of microalbuminuria. Diabetes Care. 1997;20:1642-1646.
19. 2B-adrenergic receptor gene is a novel genetic risk factor for acute coronary events. J Am Coll Cardiol. 2001;37:1516-1522.
20. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen M, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683-689.
21. McAlister F, Straus S. Measurement of blood pressure: an evidence based review. BMJ. 2001;322:908-911.
22. 2B-adrenergic receptor in the development of salt-induced hypertension. Hypertension. 1999;33:14-17.
23. 2B-adrenergic receptor antisense in plasmid vector prolongs reversal of salt-dependent hypertension. J Hypertens. 2003;21:961-967.
24. Sharma A, Schorr U. Salt sensitivity and insulin resistance: is there a link? Blood Press Suppl. 1996;1:59-63.
25. Weinberger M, Miller J, Luft F, Grim C, Fineberg M. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension. 1986;8:11127-11134.
26. 2-adrenergic receptor subtypes b and c. Science. 1996;273:803-805.